+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid therapy from primary biliary cirrhosis progression of disease despite near normalization of biochemical liver tests



Ursodeoxycholic acid therapy from primary biliary cirrhosis progression of disease despite near normalization of biochemical liver tests



Hepatology 12(4 Part 2): 843




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144909

Download citation: RISBibTeXText


Related references

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology 32(6): 1196-1199, 2000

Five year sustained biochemical improvement in ursodeoxycholic acid treated primary biliary cirrhosis does not preclude disease progression. Journal of Hepatology 26(Suppl. 1): 169, 1997

Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Liver International 28(6): 787-797, 2008

Biochemical response to ursodeoxycholic acid predicts progression of primary biliary cirrhosis. Hepatology 26(4 Part 2): 400A, 1997

Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology 102(4 Pt 1): 1389-1391, 1992

Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology 107(2): 628, 1994

Greater biliary enrichment and improved liver tests with higher doses of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 120(5 Suppl. 1): A 574, 2001

Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis. Digestive & Liver Disease 34(7): 523-527, 2002

Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis. Zeitschrift für Gastroenterologie 43(9): 1051-1059, 2005

Short-term ursodeoxycholic acid therapy delays stage progression in patients with primary biliary cirrhosis. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A900, 2000

Primary biliary cirrhosis Standard liver function tests during long term treatment with ursodeoxycholic acid and value of serial quantitative liver function tests. Gastroenterology 112(4 Suppl. ): A1377, 1997

Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Alimentary Pharmacology & Therapeutics 24(5): 813-820, 2006

Effect of long term ursodeoxycholic acid treatment on quantitative liver function tests in primary biliary cirrhosis. European Journal of Clinical Investigation 21(2 Part 2): 52, 1991

Effects of ursodeoxycholic acid udca on liver function tests and bile acid metabolism in anicteric primary biliary cirrhosis pbc a dose response study. Hepatology 8(5): 1266, 1988

Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?. Liver Transplantation and Surgery 5(4): 334-337, 1999